Banner

GWAS-related eQTLs across different cancer types

We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions ( ≥ 0.5).



e.g., "STAD"
e.g., "r²>= 0.8"
e.g., "rs2273"
Cancer type
eQTL type
tagSNP
LD
SNP ID
SNP position (hg19)
Gene symbol
Gene position (hg19)
Beta
t-stat
p-value
GWAS-Traits
THYM cis rs10935120 1 rs6806417 chr3:134211446 ANAPC13 chr3:134196547-134204865:- -0.62 -6.95 4.58E-10 Height
THYM cis rs10935120 1 rs6806417 chr3:134211446 CEP63 chr3:134204575-134293852:+ -0.42 -5 2.66E-6 Height
THYM cis rs9815354 1 rs6807015 chr3:41754514 ULK4 chr3:41288091-42003660:- 0.99 10.12 9.3E-17 Diastolic blood pressure
THYM cis rs9876781 1 rs6810060 chr3:48434748 TREX1 chr3:48501186-48509043:+ -0.28 -4.38 3.06E-5 Longevity
THYM cis rs1577917 1 rs68171315 chr6:86707400 SNHG5 chr6:86386726-86388451:- -0.57 -6.96 4.28E-10 Response to antipsychotic treatment
THYM cis rs2243480 1 rs68189316 chr7:65409169 CCT6P1 chr7:65216092-65228661:+ 0.62 5.13 1.51E-6 Diabetic kidney disease
THYM cis rs2273 1 rs6827617 chr4:76916146 NAAA chr4:76831809-76862166:- -0.45 -4.79 6.23E-6 Longevity
THYM cis rs568617 1 rs687672 chr11:65649984 CTSW chr11:65647284-65651212:+ 0.58 6.95 4.54E-10 Crohn's disease
THYM cis rs568617 1 rs687672 chr11:65649984 SNX32 chr11:65601410-65621170:+ -0.54 -5.02 2.4E-6 Crohn's disease
THYM cis rs10461617 1 rs6885541 chr5:56110857 C5orf35 chr5:56205103-56213010:+ 0.74 8.92 3.44E-14 Type 2 diabetes
THYM cis rs6911965 1 rs6901703 chr6:24475300 GPLD1 chr6:24428405-24489850:- -0.46 -4.69 9.22E-6 Hematological and biochemical traits
THYM cis rs9369898 1 rs6902429 chr6:49393500 CENPQ chr6:49431096-49460820:+ -0.3 -5.65 1.67E-7 Homocysteine levels
THYM cis rs6911965 1 rs6910460 chr6:24471712 GPLD1 chr6:24428405-24489850:- 0.45 4.67 9.97E-6 Hematological and biochemical traits
THYM cis rs6911965 1 rs6911965 chr6:24480295 GPLD1 chr6:24428405-24489850:- -0.52 -4.97 3.0E-6 Hematological and biochemical traits
THYM cis rs1577917 1 rs6914463 chr6:86653415 SNHG5 chr6:86386726-86388451:- -0.57 -7.62 1.9E-11 Response to antipsychotic treatment